Unlocking the Mystery of Alzheimer's Disease: Controversies over Hypotheses

Struggling Search for the Best Disease-modifying Approach
Share this:
Published: 13 Feb 2013

This market insight compares and contrasts the various hypotheses postulated based on Alzheimer's disease-modifying drug candidates under investigation in clinical trials. The mechanisms based on the two hallmark features of the disease, namely beta-amyloid and tau protein, have been analysed in detail. A brief overview of the other range of disease targets have also been provided.



Features of this research


Help Desk

Full list of offices

For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..